Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Lipocine Inc. | tm205342-1_10k.htm |
| EX-32.1 - EXHIBIT 32.1 - Lipocine Inc. | tm205342d1_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Lipocine Inc. | tm205342d1_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Lipocine Inc. | tm205342d1_ex31-1.htm |
| EX-23.1 - EXHIBIT 23.1 - Lipocine Inc. | tm205342d1_ex23-1.htm |
| EX-21.1 - EXHIBIT 21.1 - Lipocine Inc. | tm205342d1_ex21-1.htm |
| EX-4.6 - EXHIBIT 4.6 - Lipocine Inc. | tm205342d1_ex4-6.htm |
EXHIBIT 32.2
CERTIFICATION
In connection with the Annual Report on Form 10-K of Lipocine Inc. (the “Corporation”) for the year ended December 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Morgan R. Brown, Executive Vice President and Chief Financial Officer of the Corporation, hereby certifies, pursuant to Rule 13a-14(b) or Rule 15d-14(d) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Corporation.
| Dated: March 13, 2020 | /s/ Morgan R. Brown |
| Morgan R. Brown, Executive Vice President and Chief Financial Officer (Principal Financial and Accounting Officer) |